Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This study is a randomized, prospective, comparative study of the effectiveness of
prophylactic entecavir treatment for HBV reactivation in past HBV infected patients (HBsAg-,
HBcIgG+) with hematopoietic stem cell transplantation.